Agreement Between China National Insurance System And Drug Firms Yields Big Price Cuts In Exchange For Market Access
The latest round of negotiations between the Chinese government and pharmaceutical firms has yielded massive price cuts for consumers in the country on more than 65 new brand-name drugs in return for access to the second-largest pharmaceutical market in the world. The... Read More